Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00423761 · ClinicalTrials.gov registry record · Phase 1
An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00423761 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 25 participants.
The verdict
NCT00423761, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will evaluate any effect of single and repeated administration of GW876008 on the metabolism of midazolam in healthy volunteers.
Interventions
- DRUG midazolam
- DRUG GW876008
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00423761
The ClinicalTrials.gov registry entry for NCT00423761 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which midazolam is the first listed.
NCT00423761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00423761 about?
NCT00423761 is a clinical study titled "An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.". This study will evaluate any effect of single and repeated administration of GW876008 on the metabolism of midazolam in healthy volunteers.
What is the current status of trial NCT00423761?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2006-12.
What interventions are being tested in trial NCT00423761?
The interventions under investigation include: midazolam (DRUG), GW876008 (DRUG).
Who is sponsoring clinical trial NCT00423761?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.